Example: Heart Attack

Search clinical trials for: decrease of sedation doses and switch of ventilator settings

Total 10000 results

NCT01636154

Completed

Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations

Ischemic Stroke
NCT02183324

Completed

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
NCT02867319

Completed

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Meningococcal
NCT06771115

Completed

Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity

Obesity
NCT03606460

Completed

A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)

Multiple Sclerosis
NCT02844712

Terminated

Negative Predictive Value of Drug Provocation Tests to Beta-lactams (NPVDPT)

Drug Hypersensitivity
NCT00430248

Completed

Efficacy and Safety of Oral Febuxostat in Participants With Gout (CONFIRMS)

Gout
NCT00187551

Completed

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

HIV Infections
NCT00683176

Completed

Effect of Choline Fenofibrate (SLV348) on Macular Edema

Diabetic Macular Edema
NCT00619801

Completed

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin (PAL)

Allergic Rhinitis | Chronic Urticaria
NCT00315523

Completed

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

Rhinitis, Allergic, Seasonal
NCT00421109

Completed

Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria

Urticaria
NCT00637585

Completed

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

Allergic Rhinitis
NCT00636870

Completed

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

Allergic Rhinitis
NCT00044811

Completed

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

Asthma
NCT01935882

Completed

Low Dose Primaquine for Clearance of Gametocytes (LOPRIM)

Malaria | Plasmodium Falciparum | Asymptomatic Malaria
NCT00288158

Completed

Primary Prevention of Hypertension in Obese Adolescents

Obesity | Hyperuricemia | Pre-Hypertension
NCT01193218

Completed

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
NCT04954989

Not yet recruiting

Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers (RUBI)

Healthy
NCT04640194

Completed

A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 (TRISTARDS)

Acute Respiratory Distress Syndrome
NCT04360824

Completed

Covid-19 Associated Coagulopathy

COVID 19 Associated Coagulopathy
NCT03271879

Unknown

Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients (ERA-HF)

Heart Failure | Diabetes Mellitus | Arrythmia
NCT06005558

Completed

Low Dose Versus High Dose Methylene Blue in Septic Patients

Septic Shock
NCT07211828

Recruiting

EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives (SED-ERCP)

Anesthesia, General | Cholangiopancreatography, Endoscopic Retrograde | Sedation and Analgesia
NCT03791424

Completed

Changes of Skin Resistance After Midazolam and After the End of Anaesthesia

Anesthesia
NCT05028374

Completed

COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

Multiple Myeloma | AL Amyloidosis | Chronic Lymphocytic Leukemia
NCT04885426

Recruiting

Metformin for the Prevention of CRA Recurrence

Colorectal Adenoma | Metformin | Chemoprevention
NCT01340833

Completed

Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Cancer
NCT06234033

Recruiting

Neural Mechanisms of Sensory Processing Anomalies

Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Sensory Processing Disorder
NCT01581944

Completed

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Fibroids
NCT02260089

Completed

Telmisartan in Mild to Moderate Hypertensive Patients

Hypertension
NCT01340326

Completed

The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling (VALID)

Myocardial Infarction
NCT02242370

Completed

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension (MicCAT)

Hypertension
NCT00394966

Completed

A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)

Nausea | Vomiting
NCT03536325

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants

Healthy
NCT00558571

Completed

4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2
NCT00645801

Completed

Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation (PEG)

Colonoscopy
NCT00525824

Completed

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (GRAVITY)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
NCT02214121

Completed

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease (HESTIA 1)

Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
NCT01151449

Terminated

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer
NCT06034158

Recruiting

Molecular Basis of Loss Aversion

Healthy
NCT01230957

Completed

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Diarrhea | Clostridium Difficile Infection
NCT05901350

Completed

The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation

Parkinson Disease | Visual Impairment
NCT06842368

Recruiting

Immediate Implant Placement Using Xenograft Mixed with Vitamin D Versus Hyaluronic Acid.

Immediate Implant Placement
NCT05046223

Completed

Comparison of iGel and THRIVE on Bronchoscopic Interventions

Lung Diseases | Tracheal Diseases | Total Intravenous Anesthesia
NCT04256733

Completed

Cough Desensitization Therapy for Cough Hypersensitivity Syndrome

Cough
NCT02145091

Completed

Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Healthy
NCT00314080

Completed

Treatment of Survivors After Botulism Outbreak

Respiratory Failure | Botulism
NCT05754528

Active, not recruiting

Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance (REaCT-TEMPO)

Breast Cancer
NCT06554041

Recruiting

Soft Tissue Response to Different Restorative Materials Used in Implant Dentistry

Peri-Implantitis | Peri-implant Mucositis | Edentulous Alveolar Ridge | Prosthetic Infection | Prosthetic Complication

Search clinical trials for: decrease of sedation doses and switch of ventilator settings

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations